NO764025L - - Google Patents

Info

Publication number
NO764025L
NO764025L NO764025A NO764025A NO764025L NO 764025 L NO764025 L NO 764025L NO 764025 A NO764025 A NO 764025A NO 764025 A NO764025 A NO 764025A NO 764025 L NO764025 L NO 764025L
Authority
NO
Norway
Prior art keywords
pyridine
amino
compound
mono
imidazo
Prior art date
Application number
NO764025A
Other languages
English (en)
Norwegian (no)
Inventor
R J Bochis
P Kulsa
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO764025L publication Critical patent/NO764025L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO764025A 1975-12-09 1976-11-25 NO764025L (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63903475A 1975-12-09 1975-12-09

Publications (1)

Publication Number Publication Date
NO764025L true NO764025L (es) 1977-06-10

Family

ID=24562456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764025A NO764025L (es) 1975-12-09 1976-11-25

Country Status (25)

Country Link
US (1) US4096264A (es)
JP (1) JPS5273896A (es)
AR (1) AR222960A1 (es)
AT (1) AT361475B (es)
AU (1) AU505045B2 (es)
BE (1) BE849123A (es)
CA (1) CA1084930A (es)
CH (1) CH626362A5 (es)
DE (1) DE2655681A1 (es)
DK (1) DK529276A (es)
ES (1) ES453947A1 (es)
FI (1) FI763343A (es)
FR (1) FR2334357A1 (es)
GB (1) GB1524589A (es)
GR (1) GR62009B (es)
IL (1) IL51024A (es)
NL (1) NL7613160A (es)
NO (1) NO764025L (es)
NZ (1) NZ182756A (es)
OA (1) OA05506A (es)
PH (1) PH12259A (es)
PL (1) PL103751B1 (es)
PT (1) PT65915B (es)
SE (1) SE430504B (es)
ZA (1) ZA767331B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
US4154835A (en) * 1977-10-12 1979-05-15 Merck & Co., Inc. Anthelmintic imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US4221796A (en) * 1979-09-19 1980-09-09 E. R. Squibb & Sons, Inc. Substituted imidazolo-pyridines and method
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4507481A (en) * 1983-07-29 1985-03-26 Pennwalt Corporation Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines
IT1173196B (it) * 1984-02-02 1987-06-18 Bellon Roger Schoum Rbs Pharma Composti imidazopiridinici farmacologicamente attivi
US5214138A (en) * 1989-12-20 1993-05-25 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same
DE69108138T2 (de) * 1990-07-30 1995-07-06 Takeda Chemical Industries Ltd Imidazopyridinderivate und ihre Verwendung.
AU7583098A (en) * 1998-05-20 1999-12-06 Eli Lilly And Company Anti-viral compounds
US6358971B1 (en) 1998-05-20 2002-03-19 Eli Lilly And Company Anti-viral compounds
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DK1737459T3 (da) * 2004-03-19 2009-10-26 Warner Lambert Co Imidazopyridin og imidazopyrimidinderivater som antibakterielle midler
ES2343640T3 (es) * 2004-08-12 2010-08-05 Amgen Inc. Bisaril-sulfonamidas.
EP2162445B1 (en) * 2007-06-05 2013-11-27 Takeda Pharmaceutical Company Limited Heterobicyclic compounds as kinase inhibitors
US8431608B2 (en) 2007-08-17 2013-04-30 Icagen Inc. Heterocycles as potassium channel modulators
EP2178373B1 (en) * 2007-08-17 2013-01-23 Icagen, Inc. Heterocycles as potassium channel modulators
EP2181987B9 (en) * 2007-08-23 2014-09-03 Takeda Pharmaceutical Company Limited 2-Carbonylaminobenzothiazoles and their use for the prophylaxis and treatment of cancer
US8344135B2 (en) * 2007-08-29 2013-01-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP2277881A4 (en) 2008-04-18 2011-09-07 Shionogi & Co HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
WO2009136663A1 (en) * 2008-05-08 2009-11-12 Takeda Pharmaceutical Company Limited Fused heterocyclic derivatives and use thereof
WO2010064611A1 (ja) * 2008-12-01 2010-06-10 武田薬品工業株式会社 複素環化合物およびその用途
JO3101B1 (ar) * 2008-12-02 2017-09-20 Takeda Pharmaceuticals Co مشتقات بنزوثيازول كعوامل مضادة للسرطان
EP3205647B1 (en) 2009-08-17 2020-05-13 Memorial Sloan-Kettering Cancer Center 2-(pyrimidin-5-yl)-thiopyrimidine derivatives as hsp70 and hsc70 modulators for the treatment of proliferative disorders
ES2774975T3 (es) 2014-05-13 2020-07-23 Memorial Sloan Kettering Cancer Center Moduladores de hsp70 y métodos para fabricar y utilizar el mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701780A (en) * 1970-09-18 1972-10-31 Merck & Co Inc Imidazo(1,2-a)pyridines
JPS5124517B1 (es) * 1971-03-15 1976-07-24

Also Published As

Publication number Publication date
DE2655681A1 (de) 1977-06-16
PH12259A (en) 1978-12-12
GR62009B (en) 1979-02-15
PT65915B (en) 1978-11-07
GB1524589A (en) 1978-09-13
IL51024A0 (en) 1977-01-31
NZ182756A (en) 1979-11-01
BE849123A (fr) 1977-06-07
ATA901876A (de) 1980-08-15
CA1084930A (en) 1980-09-02
CH626362A5 (es) 1981-11-13
DK529276A (da) 1977-06-10
AU2010276A (en) 1978-06-08
OA05506A (fr) 1981-04-30
FR2334357B1 (es) 1982-10-15
FR2334357A1 (fr) 1977-07-08
ES453947A1 (es) 1978-03-01
SE430504B (sv) 1983-11-21
SE7613128L (sv) 1977-06-10
FI763343A (es) 1977-06-10
AU505045B2 (en) 1979-11-08
PL103751B1 (pl) 1979-07-31
PT65915A (en) 1977-01-01
NL7613160A (nl) 1977-06-13
IL51024A (en) 1981-12-31
JPS5273896A (en) 1977-06-21
AR222960A1 (es) 1981-07-15
AT361475B (de) 1981-03-10
JPS6126545B2 (es) 1986-06-20
US4096264A (en) 1978-06-20
ZA767331B (en) 1978-07-26

Similar Documents

Publication Publication Date Title
NO764025L (es)
NO170727B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater
KR900003496B1 (ko) 티에닐 축합 피라졸 유도체의 제조방법
US5891895A (en) Hydroxypyridine derivatives their production and use
Heber et al. The vilsmeier reaction in the synthesis of 3‐substituted [1] benzopyrano [4, 3‐b] pyridin‐5‐ones. An unusual pyridine ring closure
Haas et al. The synthesis of pyridine derivatives from 3‐formylchromone
US6015905A (en) Process for the preparation of 2-(6-substituted pyrid-2-yloxymethyl) phenylacetate
CN116987112A (zh) 制备氨基嘧啶衍生物的改善方法
NO132932B (es)
CA2584307A1 (en) Indane amides with antiproliferative activity
Miyamoto et al. Pyridonecarboxylic acids as antibacterial agents. VIII. An alternative synthesis of enoxacin via fluoronicotinic acid derivatives
CN108822002A (zh) 一种超声辅助合成n-芳基磺酰胺的方法
US4177274A (en) Substituted imidazo [1,2-a] pyridines
Tominaga et al. A new synthesis of imidazo [1, 2‐a] pyridine and imidazo [2, 1‐a] isoquinoline derivatives
Tominaga et al. Synthesis of 2‐methylthioindolizine‐3‐carbonitriles using nitro ketene dithioacetal
Bhuiyan et al. Fused pyrimidines. Part III: synthesis and antimicrobial activity of some furopyrimidines and imidazopyrazolopyrimidine
US4622326A (en) 6H-isoxazolo(5,4-d)pyrazolo(3,4-b)pyridines, and their use as antihypertensive and analgesic agents
US4237300A (en) Certain 6-substituted-2-pyridinamines
Proudfoot et al. A novel Smiles rearrangement gives access to the A-ring pyridine isomers of the nevirapine ring system
Vasilevsky et al. Unmasking of aminoanthroquinone moiety through a ring opening in the presence of copper salts and a subsequent cross-coupling/recyclization cascade
US4882338A (en) Substituted isoquinoline derivatives and anti-ulcer agents
US5739340A (en) Indolizine derivatives with pharmaceutical activity
US5028710A (en) Process for the preparation of derivatives of sulfonyl indolizine and their use as synthetic intermediates
US4549019A (en) Pyrimidinecarbamate derivatives as intermediates
IL159792A (en) History of variolins and pharmaceutical preparations containing them